Results per Page:
Clinical cancer research in the U.S. is increasingly dominated by pharmaceutical industry sponsors, study finds
Study underscores need for increased investment in federally funded cancer clinical trials
One in five people with cancer participate in medical research studies
Study sheds light on how policies can further increase access to and participation in cancer research
Policy to expand Medicaid coverage linked to higher participation in cancer clinical trials among people insured by Medicaid
Study showed that the Affordable Care Act Medicaid expansion resulted in improvements in access to clinical trials for cancer patients with Medicaid insurance
Examining the role of financial worry in cancer survivorship
From the Jones and Newcomb Labs, Public Health Sciences Division
The utility of Survivorship Care Plans for rural cancer survivors
From the Chow Studies Group, Public Health Sciences Division
Q&A: How your blood could help a cancer patient
Donated blood is in short supply. That’s a problem for many people with cancer.
New grants help community organizations overcome health disparities across Washington
Community Grant Program supports 11 projects aimed at cancer prevention, screening and more among marginalized groups
Dr. Michael Linenberger honored for contributions to apheresis medicine
Presidential Award from American Society for Apheresis recognizes hematologist’s two decades of service
Science Says: Renew, refocus, reduce risk
Lowering risk of cancer through the science of prevention
Cancer clinical trials exclude too many patients: That’s changing
Calls for equity, inclusion and better access boost pre-pandemic efforts to open up eligibility, streamline trials
Science Says: Curing cancer for all
Reducing health disparities, increasing diversity in cancer treatment and research
Black with cancer: ‘It shouldn’t be different’
Hutch/UW Consortium health equity team works to reduce cancer risk and racial bias, improve care for Black communities and patients
Challenges and Recommendations for COVID-19 Vaccines in patients with cancer
The Lyman Group, Division of Public Health Sciences
What's a cancer registry?
These large national databases track cancer trends, spotlight health disparities and improve patient care; new linkages allow for even more
One more hat: new roles for TGFβ in the DNA damage response
From the Paulovich Lab, Clinical Research Division, and colleagues
Outlining the molecular networks that alter cell function and behavior
Dr. Taran Gujral’s NSF CAREER Award will allow him to study how cells shift to new functional states in normal development and disease
Short H2A histones, part II: a natural-born oncogene lurking in our genomes
From the Malik, Henikoff, Bleakley, and Bradley labs, Basic Sciences Division
Democratizing DNA-based health risk scores
Hutch-led consortium receives $9.8M grant to improve genetic risk prediction for cardiovascular disease in racially and ethnically diverse populations
Patients navigate cancer during COVID-19 pandemic
Scary waiting rooms, delayed scans and ‘virtual’ care: patients and providers try to dodge the collateral damage of coronavirus